EGLADEA Trademark

Trademark Overview

On Monday, October 18, 2010, a trademark application was filed for EGLADEA with the United States Patent and Trademark Office. The USPTO has given the EGLADEA trademark a serial number of 85155476. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 26, 2014. This trademark is owned by Vertex Pharmaceuticals Incorporated. The EGLADEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis, viral diseases, bacterial infections, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
egladea

General Information

Serial Number85155476
Word MarkEGLADEA
Filing DateMonday, October 18, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 26, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis, viral diseases, bacterial infections, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 22, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, May 27, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 26, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 14, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 14, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2013EXTENSION 4 GRANTED
Friday, October 25, 2013EXTENSION 4 FILED
Friday, October 25, 2013TEAS EXTENSION RECEIVED
Friday, May 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2013EXTENSION 3 GRANTED
Thursday, April 25, 2013EXTENSION 3 FILED
Thursday, April 25, 2013TEAS EXTENSION RECEIVED
Friday, October 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 25, 2012EXTENSION 2 GRANTED
Tuesday, October 23, 2012EXTENSION 2 FILED
Wednesday, October 24, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 23, 2012TEAS EXTENSION RECEIVED
Thursday, April 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 24, 2012EXTENSION 1 GRANTED
Tuesday, April 24, 2012EXTENSION 1 FILED
Tuesday, April 24, 2012TEAS EXTENSION RECEIVED
Tuesday, October 25, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 27, 2011ASSIGNED TO LIE
Wednesday, July 6, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, July 6, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2011EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 26, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 26, 2011NON-FINAL ACTION E-MAILED
Wednesday, January 26, 2011NON-FINAL ACTION WRITTEN
Wednesday, January 26, 2011ASSIGNED TO EXAMINER
Friday, October 22, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 21, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

egladea diseases autoimmune cancer inflammatory neurological epilepsy disorders infections bacterial treatment